Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Acomplia (rimonabant) on esophageal sensitivity and gastric accommodation in healthy volunteers
2011-003104-20Phase 4Completed
- Sponsor
- UZ Leuven
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial comparing Rimonabant (Acomplia) with Placebo (2 arms). Primary endpoint: Esophageal sensitivity comparison. Started Aug 2011; status: completed.
02
Drugs
rimonabant
Beyond the preview
Go deeper on 2011-003104-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003104-20.